Literature DB >> 15690995

Tests for equality of survival distributions against non-location alternatives.

Vilijandas B Bagdonavicius1, Ruta J Levuliene, Mikhail S Nikulin, Olga Zdorova-Cheminade.   

Abstract

We propose new two and k-sample tests for evaluating the equality of survival distributions against alternatives that include crossing of survival functions, and proportional and monotone hazard ratios. The tests allow for right censored data. The asymptotic power against local alternatives is investigated. Simulation results demonstrate that the new tests are more powerful than known tests when survival functions cross. We apply the tests to a well known study of chemo- and radio-therapy conducted by the Gastrointestinal Tumor Study Group. The P-values for both proposed tests are much smaller than for other known tests.

Entities:  

Mesh:

Year:  2004        PMID: 15690995     DOI: 10.1007/s10985-004-4777-7

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  4 in total

1.  Validation of a heteroscedastic hazards regression model.

Authors:  Hong-Dar Isaac Wu; Fushing Hsieh; Chen-Hsin Chen
Journal:  Lifetime Data Anal       Date:  2002-03       Impact factor: 1.588

2.  A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES.

Authors:  E A GEHAN
Journal:  Biometrika       Date:  1965-06       Impact factor: 2.445

3.  A two-sample test sensitive to crossing hazards in uncensored and singly censored data.

Authors:  D M Stablein; I A Koutrouvelis
Journal:  Biometrics       Date:  1985-09       Impact factor: 2.571

4.  A comparison of combination chemotherapy and combined modality therapy for locally advanced gastric carcinoma. Gastrointestinal Tumor Study Group.

Authors: 
Journal:  Cancer       Date:  1982-05-01       Impact factor: 6.860

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.